Epinastine Hydrochloride
- Generic Name: epinastine hydrochloride
- Brand Name: Epinastine Hydrochloride Ophthalmic Solution
Epinastine Hydrochloride Ophthalmic Solution (Epinastine Hydrochloride) side effects drug center
Epinastine Hydrochloride Side Effects Center
Epinastine Hydrochloride Ophthalmic Solution 0.05% is an H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. Epinastine Hydrochloride Ophthalmic Solution 0.05% is available in generic form. Common side effects of Epinastine Hydrochloride OSolution 0.05% include:
- burning sensation in the eye,
- eye redness,
- eye itching,
- hair bumps,
- infection (cold symptoms and upper respiratory infection),
- headache,
- runny nose,
- sinus infection,
- increased cough, and
- sore throat.
The recommended dosage of of epinastine hydrochloride ophthalmic solution 0.05% is one drop in each eye twice a day. Epinastine hydrochloride ophthalmic solution 0.05% may interact with other drugs. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using epinastine hydrochloride ophthalmic solution0.05%; it is unknown how it will affect a fetus. It is unknown if Epinastine Hydrochloride Ophthalmic Solution 0.05% passes into breast milk. Consult your doctor before breastfeeding.
Our Epinastine Hydrochloride Ophthalmic Solution 0.05% Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Epinastine Hydrochloride Consumer Information
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using epinastine ophthalmic and call your doctor at once if you have a serious side effect such as:
- swelling, redness, severe discomfort, crusting or drainage (around your eyelids); or
- severe burning, stinging, or other irritation after using the eye drops.
Less serious side effects may include:
- mild burning, itching, or eye irritation;
- watery eyes;
- headache; or
- cold symptoms such as stuffy nose, sneezing, sore throat.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Epinastine Hydrochloride (Epinastine Hydrochloride)
Epinastine Hydrochloride Professional Information
SIDE EFFECTS
Clinical Studies Experience
Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.
The most frequently reported ocular adverse reactions occurring in approximately 1 to 10% of patients were burning sensation in the eye, folliculosis, hyperemia, and pruritus.
The most frequently reported non-ocular adverse reactions were infection (cold symptoms and upper respiratory infections), seen in approximately 10% of patients, and headache, rhinitis, sinusitis, increased cough, and pharyngitis, seen in approximately 1 to 3% of patients.
Some of these reactions were similar to the underlying disease being studied.
Postmarketing Experience
The following reactions have been identified during postmarketing use of epinastine HCl in clinical practice. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. The reactions, which have been chosen for inclusion due to either their seriousness, frequency of reporting, possible causal connection to epinastine HCl, or a combination of these factors, include: lacrimation increased.
Read the entire FDA prescribing information for Epinastine Hydrochloride (Epinastine Hydrochloride)
&Copy; Epinastine Hydrochloride Patient Information is supplied by Cerner Multum, Inc. and Epinastine Hydrochloride Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.